Brazil · Delayed Price · Currency is BRL Dexco Statistics
Total Valuation
Dexco has a market cap or net worth of BRL 4.30 billion. The enterprise value is 10.84 billion.
| Market Cap | 4.30B |
| Enterprise Value | 10.84B |
Important Dates
The last earnings date was Wednesday, November 5, 2025.
| Earnings Date | Nov 5, 2025 |
| Ex-Dividend Date | Mar 18, 2025 |
Share Statistics
Dexco has 810.40 million shares outstanding. The number of shares has increased by 0.11% in one year.
| Current Share Class | 810.40M |
| Shares Outstanding | 810.40M |
| Shares Change (YoY) | +0.11% |
| Shares Change (QoQ) | +0.99% |
| Owned by Insiders (%) | 19.49% |
| Owned by Institutions (%) | 34.90% |
| Float | 298.10M |
Valuation Ratios
The trailing PE ratio is 38.75 and the forward PE ratio is 15.81. Dexco's PEG ratio is 0.55.
| PE Ratio | 38.75 |
| Forward PE | 15.81 |
| PS Ratio | 0.52 |
| PB Ratio | 0.62 |
| P/TBV Ratio | 0.73 |
| P/FCF Ratio | 647.49 |
| P/OCF Ratio | 4.52 |
| PEG Ratio | 0.55 |
Enterprise Valuation
The stock's EV/EBITDA ratio is 6.34, with an EV/FCF ratio of 1,630.90.
| EV / Earnings | 97.52 |
| EV / Sales | 1.32 |
| EV / EBITDA | 6.34 |
| EV / EBIT | 19.37 |
| EV / FCF | 1,630.90 |
Financial Position
The company has a current ratio of 1.33, with a Debt / Equity ratio of 1.14.
| Current Ratio | 1.33 |
| Quick Ratio | 0.84 |
| Debt / Equity | 1.14 |
| Debt / EBITDA | 5.09 |
| Debt / FCF | 1,199.13 |
| Interest Coverage | 0.49 |
Financial Efficiency
Return on equity (ROE) is 1.95% and return on invested capital (ROIC) is 1.75%.
| Return on Equity (ROE) | 1.95% |
| Return on Assets (ROA) | 1.43% |
| Return on Invested Capital (ROIC) | 1.75% |
| Return on Capital Employed (ROCE) | 2.99% |
| Revenue Per Employee | 577,481 |
| Profits Per Employee | 7,812 |
| Employee Count | 14,228 |
| Asset Turnover | 0.45 |
| Inventory Turnover | 3.82 |
Taxes
| Income Tax | -123.65M |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -29.76% in the last 52 weeks. The beta is 0.36, so Dexco's price volatility has been lower than the market average.
| Beta (5Y) | 0.36 |
| 52-Week Price Change | -29.76% |
| 50-Day Moving Average | 5.36 |
| 200-Day Moving Average | 5.54 |
| Relative Strength Index (RSI) | 51.21 |
| Average Volume (20 Days) | 2,429,665 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Dexco had revenue of BRL 8.22 billion and earned 111.15 million in profits. Earnings per share was 0.14.
| Revenue | 8.22B |
| Gross Profit | 1.91B |
| Operating Income | 418.36M |
| Pretax Income | 10.05M |
| Net Income | 111.15M |
| EBITDA | 1.49B |
| EBIT | 418.36M |
| Earnings Per Share (EPS) | 0.14 |
Balance Sheet
The company has 1.51 billion in cash and 7.97 billion in debt, giving a net cash position of -6.29 billion or -7.76 per share.
| Cash & Cash Equivalents | 1.51B |
| Total Debt | 7.97B |
| Net Cash | -6.29B |
| Net Cash Per Share | -7.76 |
| Equity (Book Value) | 6.99B |
| Book Value Per Share | 8.32 |
| Working Capital | 1.31B |
Cash Flow
In the last 12 months, operating cash flow was 952.30 million and capital expenditures -945.65 million, giving a free cash flow of 6.65 million.
| Operating Cash Flow | 952.30M |
| Capital Expenditures | -945.65M |
| Free Cash Flow | 6.65M |
| FCF Per Share | 0.01 |
Margins
Gross margin is 23.26%, with operating and profit margins of 5.09% and 1.35%.
| Gross Margin | 23.26% |
| Operating Margin | 5.09% |
| Pretax Margin | 0.12% |
| Profit Margin | 1.35% |
| EBITDA Margin | 18.10% |
| EBIT Margin | 5.09% |
| FCF Margin | 0.08% |
Dividends & Yields
This stock pays an annual dividend of 0.05, which amounts to a dividend yield of 0.88%.
| Dividend Per Share | 0.05 |
| Dividend Yield | 0.88% |
| Dividend Growth (YoY) | -81.61% |
| Years of Dividend Growth | n/a |
| Payout Ratio | 212.31% |
| Buyback Yield | -0.11% |
| Shareholder Yield | 0.77% |
| Earnings Yield | 2.58% |
| FCF Yield | 0.15% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Stock Splits
The last stock split was on December 21, 2022. It was a forward split with a ratio of 1.1.
| Last Split Date | Dec 21, 2022 |
| Split Type | Forward |
| Split Ratio | 1.1 |
Scores
Dexco has an Altman Z-Score of 1.08 and a Piotroski F-Score of 5. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | 1.08 |
| Piotroski F-Score | 5 |